Khalid Usman, Mujeeb ur Rehman, Arif Mumtaz, Naseeb UrRehman, and Salman Khan. “EXAMINING DAPAGLIFLOZIN’S IMPACT ON CARDIOVASCULAR HEALTH IN HFREF PATIENTS: DIABETES TYPE 2 CONSIDERATION”. Journal of Population Therapeutics and Clinical Pharmacology 28, no. 2 (July 25, 2021): 418–422. Accessed November 18, 2024. https://mail.jptcp.com/index.php/jptcp/article/view/6807.